30 June 2026

MSWA commits another $5 million in neurological research for 2026/2027 financial year.

MSWA is proud to commit up to another $5 million in neurological research during the 2026/2027 financial year, continuing our investment to advancing knowledge, treatment and care for people living with MS and other neurological conditions.

This funding remains possible through the generosity of our supporters, donors, fundraising events, community partners and lottery supporters across Western Australia. Their support allows us to contribute to research that makes a genuine difference for people living with neurological conditions today while helping shape a better future for those diagnosed tomorrow.

At MSWA, we believe through strategic investment in clinical, translational and community-focused research, we can accelerate discovery, improve care and expand the options available to people living with neurological conditions in Western Australia and beyond to live their best lives.

Our research partners

MS Australia

MSWA continues its strong partnership with our national body, MS Australia, which distributes key MS research funds across Australia including a grant stream allocated to research projects aligned with MSWA’s research principles on our behalf through its established expert review panel.

PLATYPUS

MSWA remains the leading funder of PLATYPUS (PLatform Adaptive Trial for remYelination and neuroProtection in mUltiple Sclerosis), Australia’s first adaptive clinical trial for MS, testing repurposed treatments for their potential to slow or reverse damage caused by progressive MS.

Find Out More

Founders Factory

Through the MSWA Multiple Sclerosis and Neurological Care Accelerator, a world first accelerator program dedicated to neurological health and delivered with global venture builder Founders Factory, MSWA supports early-stage startups developing new technologies for people living with MS and other neurological conditions.

Find Out More

International Research

The Progressive MS Alliance, Multiple Sclerosis International Foundation

The International Progressive MS Alliance is an unprecedented global collaboration that brings together researchers, clinicians, pharmaceutical companies, and people with progressive MS, transforming the landscape of MS.